STOCK TITAN

FTNT (NASDAQ) Form 144: 155,000 shares from option exercise; May institutional sales listed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

FTNT submitted Form 144 notices reporting the proposed sale of 155,000 shares of common stock tied to an exercise of stock options, dated 06/02/2026. The filing also lists 5,632 restricted stock units dated 02/01/2026 and multiple recent institutional sales in May 2026.

The excerpt lists institutional dispositions: President and Fellows of Harvard College sold 2,034 shares on 05/19/2026 for $257,274.15, Creative Center of Los Altos sold 17,643 shares on 05/18/2026 for $2,183,144.82, UC Berkeley sold 3,941 shares on 05/18/2026 for $212,760.01, and a 10b5-1 sale by an individual shows 5,355 shares on 05/04/2026 for $476,033.80.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notice filed for option exercise and RSUs; multiple institutional sales recorded.

The filing records a proposed sale of 155,000 shares from an exercise of stock options dated 06/02/2026 and 5,632 RSUs dated 02/01/2026. These entries are procedural notices under Rule 144 for planned or qualifying sales.

Institutional sales in May 2026 are itemized with share counts and proceeds. Cash‑flow treatment and whether the company receives proceeds are not specified in the excerpt; subsequent filings would state proceeds treatment if relevant.

Notable block sizes and dollar proceeds shown for several institutional sellers in May 2026.

The excerpt lists specific dispositions: 17,643 shares for $2,183,144.82 and other institutional sales with exact proceeds and dates in May 2026. These are factual disclosures of past transactions rather than corporate actions.

Timing and intent (e.g., programmatic selling versus discretionary) are not described here; further filings or broker reports would clarify whether these are routine rebalancings or other actions.

Proposed sale (options) 155,000 shares Exercise of Stock Options dated 06/02/2026
Restricted Stock Units 5,632 shares Restricted Stock Units dated 02/01/2026
Institutional sale - Creative Center of Los Altos 17,643 shares Sold 05/18/2026 for <money>$2,183,144.82</money>
Institutional sale - Harvard 2,034 shares Sold 05/19/2026 for <money>$257,274.15</money>
10b5-1 sale (individual) 5,355 shares Sold 05/04/2026 for <money>$476,033.80</money>
Institutional sale - UC Berkeley 3,941 shares Sold 05/18/2026 for <money>$212,760.01</money>
Rule 144 regulatory
"144: Securities To Be Sold"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
10b5-1 regulatory
"10b5-1 Sales for KEN QING XIE 909 Kifer Road"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Restricted Stock Units financial
"Restricted Stock Units | Issuer | 5632 | 02/01/2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Exercise of Stock Options financial
"Exercise of Stock Options | Issuer | 155000 | 06/02/2026"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does FTNT's Form 144 report?

The Form 144 reports a proposed sale of 155,000 shares from an exercise of stock options dated 06/02/2026. It also lists 5,632 restricted stock units dated 02/01/2026 and recent institutional dispositions in May 2026.

Who sold shares in May 2026 according to the excerpt?

The excerpt shows institutional sellers: President and Fellows of Harvard College (2,034 shares), Creative Center of Los Altos (17,643 shares), and UC Berkeley (3,941 shares), with sale dates in May 2026 and stated proceeds.

Are the dollar proceeds from recent sales disclosed?

Yes. The excerpt lists proceeds: for example, $2,183,144.82 for 17,643 shares and $476,033.80 for a 10b5-1 sale of 5,355 shares. Each sale row pairs share counts with proceeds and a sale date in May 2026.

Does the filing state who receives the sale proceeds?

The provided excerpt does not state the recipient of proceeds for the proposed 155,000-share sale. The listed institutional sales include proceeds amounts, but the filing does not specify whether proceeds go to the issuer or selling holders in these lines.